Sonendo Inc
(OTCPK:SONX)
$
1.3525
-0.1975 (-12.74%)
Market Cap: 565,000.00
Enterprise Value: 2.70 Mil
PE Ratio: 0
PB Ratio: 0.05
GF Score: 36/100 Sonendo Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022 / 06:55PM GMT
Release Date Price:
$208
(-6.31%)
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst
Hi, everyone. Good afternoon. Thank you for joining us today. My name is Erin Wright. I'm Morgan Stanley's healthcare services and distribution analyst. I'm pleased to have Sonendo's CEO, Bjarne Bergheim, and then also the COO or CCO?
Michael J. Smith
Sonendo, Inc. - Chief Commercial Officer
CCO.
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst
CCO. Michael Smith, with us today. Sonendo is a commercial-stage medical technology company with a focus on the endodontics market. For important disclosures, please see Morgan Stanley research disclosure website at morganstanley.com. If you have any questions, please reach out to your Morgan Stanley sales representative.
Questions & Answers
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst
With that, thanks for having us -- or thanks. We're happy to have you here. So in terms
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot